Α-Hydroxyetizolam
| Clinical data | |
|---|---|
| Other names | α-Hydroxyetizolam |
| Dependence liability | Moderate |
| Routes of administration | Oral, sublingual, rectal |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 8.2 hours |
| Excretion | Kidney |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H15ClN4OS |
| Molar mass | 358.84 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
α-Hydroxyetizolam is the pharmacologically active metabolite of etizolam. α-Hydroxyetizolam has a half-life of approximately 8.2 hours.
Etizolam's other non-pharmacologically active metabolite in humans is 8-hydroxyetizolam.